Skip to content
10-K

Annual Report

Theravance Biopharma, Inc. TBPH

0001104659-26-033077

← back to feed
Filed
Mar 23, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 28, 2026 51.49M sh
Shares Diluted FY 2025 · Dec 31, 2025 51.51M sh
Shares Diluted FY 2025 · Dec 31, 2024 48.85M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 $238.54M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$11.54M
Cash And Equivalents FY 2025 · Dec 31, 2025 $167.81M
Cash And Equivalents FY 2025 · Dec 31, 2024 $37.8M
Stockholders Equity FY 2025 · Dec 31, 2025 $296.72M
Stockholders Equity FY 2025 · Dec 31, 2024 $175.55M
Current Liabilities FY 2025 · Dec 31, 2025 $38.3M
Current Liabilities FY 2025 · Dec 31, 2024 $32.09M
Current Assets FY 2025 · Dec 31, 2025 $418.46M
Current Assets FY 2025 · Dec 31, 2024 $161.07M
Total Assets FY 2025 · Dec 31, 2025 $485.57M
Total Assets FY 2025 · Dec 31, 2024 $354.16M
Eps Diluted FY 2025 · Dec 31, 2025 $1.15
Eps Diluted FY 2025 · Dec 31, 2025 $2.06
Eps Diluted FY 2025 · Sep 30, 2025 $0.07
Eps Diluted FY 2025 · Jun 30, 2025 $1.08
Eps Diluted FY 2025 · Mar 31, 2025 −$0.27
Eps Diluted FY 2025 · Dec 31, 2024 −$0.31
Eps Diluted FY 2025 · Dec 31, 2024 −$1.15
Eps Diluted FY 2025 · Sep 30, 2024 −$0.26
Eps Diluted FY 2025 · Jun 30, 2024 −$0.34
Eps Diluted FY 2025 · Mar 31, 2024 −$0.24
Eps Basic FY 2025 · Dec 31, 2025 $1.20
Eps Basic FY 2025 · Dec 31, 2025 $2.10
Eps Basic FY 2025 · Sep 30, 2025 $0.07
Eps Basic FY 2025 · Jun 30, 2025 $1.09
Eps Basic FY 2025 · Mar 31, 2025 −$0.27
Eps Basic FY 2025 · Dec 31, 2024 −$0.31
Eps Basic FY 2025 · Dec 31, 2024 −$1.15
Eps Basic FY 2025 · Sep 30, 2024 −$0.26
Eps Basic FY 2025 · Jun 30, 2024 −$0.34
Eps Basic FY 2025 · Mar 31, 2024 −$0.24
Sga Expense FY 2025 · Dec 31, 2025 $73.65M
Sga Expense FY 2025 · Dec 31, 2024 $69.17M
Rd Expense FY 2025 · Dec 31, 2025 $37.41M
Rd Expense FY 2025 · Dec 31, 2024 $37.64M
Net Income FY 2025 · Dec 31, 2025 $61.02M
Net Income FY 2025 · Dec 31, 2025 $105.9M
Net Income FY 2025 · Sep 30, 2025 $3.62M
Net Income FY 2025 · Jun 30, 2025 $54.84M
Net Income FY 2025 · Mar 31, 2025 −$13.58M
Net Income FY 2025 · Dec 31, 2024 −$15.53M
Net Income FY 2025 · Dec 31, 2024 −$56.42M
Net Income FY 2025 · Sep 30, 2024 −$12.7M
Net Income FY 2025 · Jun 30, 2024 −$16.53M
Net Income FY 2025 · Mar 31, 2024 −$11.66M
Operating Income FY 2025 · Dec 31, 2025 $20.01M
Operating Income FY 2025 · Dec 31, 2025 −$3.6M
Operating Income FY 2025 · Sep 30, 2025 −$6.46M
Operating Income FY 2025 · Jun 30, 2025 −$2.73M
Operating Income FY 2025 · Mar 31, 2025 −$14.43M
Operating Income FY 2025 · Dec 31, 2024 −$9.2M
Operating Income FY 2025 · Dec 31, 2024 −$46.95M
Operating Income FY 2025 · Sep 30, 2024 −$10.84M
Operating Income FY 2025 · Jun 30, 2024 −$15.71M
Operating Income FY 2025 · Mar 31, 2024 −$11.21M
Revenue FY 2025 · Dec 31, 2025 $45.89M
Revenue FY 2025 · Dec 31, 2025 $107.46M
Revenue FY 2025 · Sep 30, 2025 $19.99M
Revenue FY 2025 · Jun 30, 2025 $26.2M
Revenue FY 2025 · Mar 31, 2025 $15.39M
Revenue FY 2025 · Dec 31, 2024 $18.75M
Revenue FY 2025 · Dec 31, 2024 $64.38M
Revenue FY 2025 · Sep 30, 2024 $16.87M
Revenue FY 2025 · Jun 30, 2024 $14.26M
Revenue FY 2025 · Mar 31, 2024 $14.5M
Stock Repurchased FY 2025 · Dec 31, 2024 $445K